The current valuation score of iBio Inc is 7.37, ranking 253 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.54, which is -247.56% below the recent high of 3.75 and -80038.29% above the recent low of -2035.75.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.